Parmax Pharma Ltd - PARMAX PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE240T01014

Trade

Parmax Pharma Ltd Corporate Actions

16 Aug , 2023

12:00 AM

AGM

Announcement date: 16 Aug , 2023

View Details

07 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Aug , 2023

12:00 AM

Results

View Details

10 Jun , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Feb , 2023

12:00 AM

Results

View Details

05 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Nov , 2022

12:00 AM

Results

View Details

08 Sep , 2022

12:00 AM

AGM

Announcement date: 08 Sep , 2022

View Details

16 Aug , 2023

12:00 AM

BookCloser

View Details

Parmax Pharma Ltd News and Update

Sun Pharma will acquire its Mexican arm's completely by buying out local partner

14 hours ago |
8:36 PM

The deal will be carried out through a wholly-owned subsidiary called Sun Pharma (Netherlands) B.V., the company said, adding that it would "enable Sun Pharma to acquire the balance 25% stake held by the local partner."

Aurobindo Pharma's Unit Inks License Agreement for Pediatric Vaccine

IIFL News Service |
1 day ago |
8:34 PM

Indian Markets Close Up on September 27, PSU Banks Lead Gains

IIFL News Service |
27 September, 2023 |
8:33 PM

Aditya Birla Fashion completes purchase of 51% stake in TCNS Clothing, beco...

IIFL News Service |
27 September, 2023 |
8:33 PM

Parmax Pharma Ltd FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Parmax Pharma Ltd PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	1,159.25	67.12	2,78,106.92	380.64	0.99	4,383.34	98.98
Divis Laboratories Ltd	3,761.95	68.38	99,942.28	345.00	0.80	1,730.00	478.60
Cipla Ltd	1,189.75	34.98	95,812.44	895.02	0.72	3,857.73	305.19
Dr Reddys Laboratories Ltd	5,595.35	24.83	93,178.48	1,639.40	0.72	5,420.10	1,235.20
Torrent Pharmaceuticals Ltd	1,925.25	62.27	65,264.13	323.00	1.14	2,078.00	190.75

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

Parmax Pharma Ltd - PARMAX PHARMA Share Price

Parmax Pharma Ltd KEY RATIOS

Parmax Pharma Ltd Corporate Actions

Parmax Pharma Ltd News and Update

Sun Pharma will acquire its Mexican arm's completely by buying out local partner

Knowledge Center

Parmax Pharma Ltd SHAREHOLDING SNAPSHOT
30 September , 2023 | 01:59 AM

Parmax Pharma Ltd FINANCIALS

Select Period:

Parmax Pharma Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

QuickLinks for Parmax Pharma Ltd.

Parmax Pharma Information

Parmax Pharma Financials

Parmax Pharma Results

Parmax Pharma News

Parmax Pharma Ltd PEER COMPARISON

MORE ABOUT Parmax Pharma Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Parmax Pharma Ltd - PARMAX PHARMA Share Price

Parmax Pharma Ltd KEY RATIOS

Parmax Pharma Ltd Corporate Actions

Parmax Pharma Ltd News and Update

Sun Pharma will acquire its Mexican arm's completely by buying out local partner

Knowledge Center

Parmax Pharma Ltd SHAREHOLDING SNAPSHOT 30 September , 2023 | 01:59 AM

Parmax Pharma Ltd FINANCIALS

Select Period:

Parmax Pharma Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

QuickLinks for Parmax Pharma Ltd.

Parmax Pharma Information

Parmax Pharma Financials

Parmax Pharma Results

Parmax Pharma News

Parmax Pharma Ltd PEER COMPARISON

MORE ABOUT Parmax Pharma Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Parmax Pharma Ltd SHAREHOLDING SNAPSHOT
30 September , 2023 | 01:59 AM